Allopurinol pretreatment improves postoperative recovery and reduces lipid peroxidation in patients undergoing coronary artery bypass grafting.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Thoracic and Cardiovascular Surgery

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0022-5223(94)70478-3PMID 8283893
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A mild, rapid, and efficient method of lipid extraction for use in determining vitamin E/lipid ratios

  2006cited by this paper
• Lipid peroxidation and changes in vitamin E levels during coronary artery bypass grafting.

  1993cited by this paper
• A clinical trial of allopurinol (Zyloric) for myocardial protection.

  1991cited by this paper
• A randomized controlled trial of allopurinol in coronary bypass surgery.

  1991cited by this paper
• Influence of allopurinol on cardiac complications in open heart operations.

  1991cited by this paper
• Protection Against Postischemic Myocardial Dysfunction in Anesthetized Rabbits with Scavengers of Oxygen‐Derived Free Radicals: Superoxide Dismutase Plus Catalase, N-2‐Mercaptopropinyl Glycine and Captopril

  1991cited by this paper
• Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes.

  1991cited by this paper
• Use of spin traps in intact animals undergoing myocardial ischemia/reperfusion: a new approach to assessing the role of oxygen radicals in myocardial "stunning".

  1990cited by this paper
• Occurrence of oxidative stress during reperfusion of the human heart.

  1990cited by this paper
• Systemic pattern of free radical generation during coronary bypass surgery.

  1990cited by this paper
• An accurate, nontraumatic ultrasonic method to monitor myocardial wall thickening in patients undergoing cardiac surgery.

  1990cited by this paper
• Effect of supplementing cardioplegic solution with deferoxamine on reperfused human myocardium.

  1990cited by this paper
• Reduction of reperfusion injury with mannitol cardioplegia.

  1989cited by this paper
• Protection by Superoxide Dismutase From Myocardial Dysfunction and Attenuation of Vasodilator Reserve After Coronary Occlusion and Reperfusion in Dog

  1989cited by this paper
• Oxidation and release of glutathione from myocardium during early reperfusion.

  1989cited by this paper
• Absence of detectable xanthine oxidase in human myocardium.

  1989cited by this paper
• Myocardial free-radical injury after cardioplegia.

  1989cited by this paper
• Marked Reduction of Free Radical Generation and Contractile Dysfunction by Antioxidant Therapy Begun at the Time of Reperfusion Evidence That Myocardial "Stunning" Is a Manifestation of Reperfusion Injury

  1989cited by this paper
• Myocardial ischemia and reperfusion: direct evidence for free radical generation by electron spin resonance spectroscopy.

  1988cited by this paper
• Assessment of myocardial oxidative stress in patients after myocardial revascularization.

  1988cited by this paper
• Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart.

  1988cited by this paper
• The role of xanthine oxidase during myocardial ischemia in several species including man.

  1988cited by this paper
• Free radical-producing enzyme, xanthine oxidase, is undetectable in human hearts.

  1987cited by this paper
• The activity of xanthine oxidase in heart of pigs, guinea pigs, rabbits, rats, and humans

  1987cited by this paper
• Evidence for a reversible oxygen radical-mediated component of reperfusion injury: reduction by recombinant human superoxide dismutase administered at the time of reflow.

  1987cited by this paper
• Increased production of peroxidation products associated with cardiac operations. Evidence for free radical generation.

  1986cited by this paper
• Superoxide generation during cardiopulmonary bypass: is there a role for vitamin E?

  1986cited by this paper
• Oxygen-mediated myocardial damage during ischaemia and reperfusion: role of the cellular defences against oxygen toxicity.

  1985cited by this paper
• ASSAY FOR SERUM LIPID PEROXIDE LEVEL AND ITS CLINICAL SIGNIFICANCE

  1982cited by this paper
• Sequential postoperative assessment of left ventricular performance with gated cardiac blood pool imaging following aortocoronary bypass surgery.

  1981cited by this paper
• Effect of allopurinol (zyloric) on patients undergoing open heart surgery.

  1979cited by this paper

• Do reactive oxygen species damage or protect the heart in ischemia and reperfusion? Analysis on experimental and clinical data

  2023cites this paper
• Allopurinol for Secondary Prevention in Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2023cites this paper
• Time-varying serum uric acid predicts new-onset atrial fibrillation in treated hypertensive patients. The LIFE Study

  2022cites this paper
• Efficacy of Allopurinol in Cardiovascular Diseases: A Systematic Review and Meta-Analysis

  2020cites this paper
• Allopurinol: Old Drug, New Indication in Neonates?

  2018cites this paper
• The adjuvant effect of allopurinol with valsartan on the treatment of essential hypertension

  2018cites this paper
• Protective Effects of Topiroxostat on an Ischemia-Reperfusion Model of Rat Hearts.

  2018cites this paper
• A meta-analysis of the efficacy of allopurinol in reducing the incidence of myocardial infarction following coronary artery bypass grafting

  2018cites this paper
• Allopurinol as a therapeutic option in cardiovascular disease

  2017influential citation
• Reactive oxygen species-mediated cardiac-reperfusion injury: Mechanisms and therapies.

  2016cites this paper
• Xanthine oxidase inhibition for the treatment of cardiovascular disease: an updated systematic review and meta‐analysis

  2016cites this paper
• ALLOPURINOL AS A PROMISING ANTI-ANGINAL AGENT: AN OLD DRUG WITH NEW INDICATION

  2015cites this paper
• Vascular Calcification in Type 2 Diabetes: A Role for Allopurinol?

  2015cites this paper
• Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis.

  2014cites this paper
• Xanthine oxidase and the fetal cardiovascular defence to hypoxia in late gestation ovine pregnancy

  2014cites this paper
• Strategies for prevention of acute kidney injury in cardiac surgery: an integrative review

  2014cites this paper
• Therapeutic Approaches to Chronic Hyperuricemia and Gout

  2014cites this paper
• An insight into prototropism and supramolecular motifs in solid-state structures of allopurinol, hypoxanthine, xanthine, and uric acid. A ¹H-¹⁴N NQDR spectroscopy, hybrid DFT/QTAIM, and Hirshfeld surface-based study.

  2014cites this paper
• Oxidase Interactions in Cardiovascular Disease 37

  2014cites this paper
• Serum uric acid and metabolic risk

  2013cites this paper
• surgery: A randomized, double-blind, placebo-controlled clinical trial -acetylcysteine on outcomes after coronary artery bypass N Effect of intravenous

  2013cites this paper
• Beyond gout: uric acid and cardiovascular diseases

  2013cites this paper
• Cardiac Ischemia and Reperfusion

  2013cites this paper
• Correlation of docking energies with spectroscopic kinetic assays of potential xanthine oxidase substrates

  2013influential citation
• Review Serum uric acid and metabolic risk

  2013cites this paper
• Reactive oxygen species in myocardial reperfusion injury: from physiopathology to therapeutic approaches.

  2012cites this paper
• The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion.

  2012cites this paper
• Allopurinol for preventing mortality and morbidity in newborn infants with hypoxic-ischaemic encephalopathy.

  2012cites this paper
• Role of oxidative stress in disease progression in Stage B, a pre-cursor of heart failure.

  2012cites this paper
• Oxygen Radical Scavengers

  2011cites this paper
• Hypertension Allopurinol Normalizes Endothelial Dysfunction in Type 2 Diabetics With Mild

  2011cites this paper
• Free radical reaction products and antioxidant capacity in beating heart coronary artery surgery compared to conventional bypass

  2011cites this paper
• Xanthine oxidase and uric acid in cardiovascular disease: clinical impact and therapeutic options.

  2011cites this paper
• Management of refractory angina pectoris.

  2011cites this paper
• Uric acid in heart disease: a new C-reactive protein?

  2011cites this paper
• Postępowanie w opornej na leczenie dławicy piersiowej

  2011cites this paper
• The prognostic impact of allopurinol in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.

  2010cites this paper
• Allopurinol Protection in Patients Undergoing Coronary Artery Bypass Graft Surgery

  2010cites this paper
• Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in gout.

  2010cites this paper
• Effect of preoperative administration of allopurinol in patients undergoing surgery for valvular heart diseases.

  2010cites this paper
• Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress

  2009cites this paper
• effects of allopurinol and vitamin e on renal function in patients with cardiac coronary artery bypass grafts

  2009cites this paper
• Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress

  2009cites this paper
• Antioxidants in the prevention of myocardial ischemia/reperfusion injury

  2009cites this paper
• Effects of allopurinol and vitamin E on renal function in patients with cardiac coronary artery bypass grafts

  2009cites this paper
• Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress

  2009cites this paper
• Allopurinol for preventing mortality and morbidity in newborn infants with suspected hypoxic-ischaemic encephalopathy.

  2008cites this paper
• Podagra, uric acid, and cardiovascular disease.

  2007cites this paper
• Uric Acid , and Cardiovascular Disease

  2007cites this paper
• Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial.

  2007cites this paper
• The role of oxidants and free radicals in reperfusion injury.

  2006cites this paper
• Could uric acid have a role in acute renal failure?

  2006cites this paper
• Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol

  2006influential citation
• Uric acid in chronic heart failure.

  2005cites this paper
• Acid as a Mediator of Endothelial ysfunction , Inflammation , and Vascular Disease

  2005cites this paper
• Acid in Chronic Heart Failure

  2005cites this paper
• Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure.

  2005cites this paper
• Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?

  2005cites this paper
• Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease.

  2005cites this paper
• Xanthine Oxidase Inhibitors and Insulin Sensitizers

  2005cites this paper
• Cell Culture Modeling to Test Therapies Against Hyperglycemia-Mediated Oxidative Stress and Injury

  2005cites this paper
• A novel method of 'preparative' myocardial protection using green tea polyphenol in oral uptake.

  2004cites this paper
• Pathobiology and Clinical Impact of Reperfusion Injury

  2004cites this paper
• Disposition and uric acid lowering effect of oxipurinol: comparison of different oxipurinol formulations and allopurinol in healthy individuals

  2004cites this paper
• Allopurinol as a Cardioprotectant during Coronary Artery Bypass Graft Surgery

  2003cites this paper
• Allopurinol improves cardiac dysfunction after ischemia-reperfusion via reduction of oxidative stress in isolated perfused rat hearts.

  2003cites this paper
• Antioxidants in myocardial ischemia-reperfusion injury: therapeutic potential and basic mechanisms.

  2003cites this paper
• N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: results of a randomized, double-blind, placebo-controlled clinical trial.

  2003cites this paper
• Allopurinol as a potential therapeutic agent for recurrent herpes labialis.

  2003cites this paper
• Nitrotyrosine and 8-isoprostane formation indicate free radical-mediated injury in hearts of patients subjected to cardioplegia.

  2003cites this paper
• Does allopurinol prevent side effects of cyclosporine-A treatment?

  2002cites this paper
• Xanthine oxidase contributes to preconditioning's preservation of left ventricular developed pressure in isolated rat heart: developed pressure may not be an appropriate end-point for studies of preconditioning

  2002cites this paper
• Reducing uric acid as a means to prevent cardiovascular and renal disease

  2002cites this paper
• Effects of Xanthine Oxidase Inhibition With Allopurinol on Endothelial Function and Peripheral Blood Flow in Hyperuricemic Patients With Chronic Heart Failure: Results From 2 Placebo-Controlled Studies

  2002cites this paper
• Antioxidant vitamins and enzymatic and synthetic oxygen-derived free radical scavengers in the prevention and treatment of cardiovascular disease.

  2001cites this paper
• Antioxidants in critical illness.

  2001cites this paper
• Oxidative pathways in cardiovascular disease: roles, mechanisms, and therapeutic implications.

  2001cites this paper
• Cardioplegia and Surgical Ischemia

  2001cites this paper
• Allopurinol neurocardiac protection trial in infants undergoing heart surgery using deep hypothermic circulatory arrest.

  2001cites this paper
• A placebo-controlled study examining the effect of allopurinol on heart rate variability and dysrhythmia counts in chronic heart failure.

  2001cites this paper
• Changes in brain natriuretic peptide concentrations following open cardiac surgery with cardioplegic cardiac arrest.

  2001cites this paper
• Excellence and low case volume: an example of the inapplicability of volume-based credentialing.

  2000cites this paper
• Preservation and protection of myocardial function.

  2000cites this paper
• Effect of allopurinol on myocardial oxygen free radical production in coronary bypass surgery.

  2000cites this paper
• Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension.

  2000cites this paper
• Effect of Allopurinol on Myocardial Oxygen Free Radical Production in Coronary Bypass Surgery

  2000influential citation
• Therapeutic strategies to reduce TNF-alpha mediated cardiac contractile depression following ischemia and reperfusion.

  1999cites this paper
• Novel Insights Into the Pathogenesis and Therapy of Circulatory Shock

  1998cites this paper
• Relation between left ventricular function and oxidative stress in patients undergoing bypass surgery

  1998cites this paper
• Free Radicals in Cardiovascular Disease

  1998cites this paper
• Ginkgo biloba extract (EGb 761) pretreatment limits free radical-induced oxidative stress in patients undergoing coronary bypass surgery.

  1997cites this paper
• Increased formation of the isoprostanes IPF2alpha-I and 8-epi-prostaglandin F2alpha in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans.

  1997cites this paper
• Ginkgo biloba Extract (EGb 761) Pretreatment Limits Free Radical Oxidative Stress in Patients Undergoing Coronary Bypass Surgery

  1997influential citation
• Increased Formation of the Isoprostanes IPF2α-I and 8-Epi-Prostaglandin F2α in Acute Coronary Angioplasty

  1997cites this paper
• Pathophysiology of chest trauma.

  1997cites this paper
• Arritmias de reperfusión en pacientes valvulares operados con cirugía extracorpórea y pretratados con captopril

  1997cites this paper
• [Reperfusion arrhythmias in valvular patients undergoing extracorporeal surgery and pretreated with captopril].

  1997cites this paper
• Free radical generation and the role of allopurinol as a cardioprotective agent during coronary artery bypass grafting surgery.

  1996cites this paper
• Failure of allopurinol to improve left ventricular stroke work after cardiopulmonary bypass surgery.

  1996cites this paper
• Uric acid lowering effect of oxipurinol sodium in hyperuricemic patients - therapeutic equivalence to allopurinol.

  1996cites this paper